Alpha Tau Medical Ltd. (DRTS)
NASDAQ: DRTS · Real-Time Price · USD
14.87
+0.10 (0.68%)
Oct 5, 2026, 10:26 AM EDT - Market open
Alpha Tau Medical Market Cap
Alpha Tau Medical has a market cap or net worth of $1.37 billion as of October 5, 2026. Its market cap has increased by 274.59% in one year.
Market Cap
1.37B
Enterprise Value
1.29B
1-Year Change
274.59%
Ranking
Category
Stock Price
$14.87
ChartMarket Cap Chart
Since March 8, 2021, Alpha Tau Medical's market cap has increased from $347.19M to $1.37B, an increase of 295.46%. That is a compound annual growth rate of 27.94%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 5, 2026 | 1.37B | 225.31% |
| Dec 31, 2025 | 422.06M | 94.21% |
| Dec 31, 2024 | 217.32M | 3.92% |
| Dec 29, 2023 | 209.12M | -4.71% |
| Dec 30, 2022 | 219.46M | -34.99% |
| Dec 31, 2021 | 337.56M | -2.77% |
| Mar 8, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Nanobiotix | 1.45B |
| Inhibrx Biosciences | 1.44B |
| Korsana Biosciences | 1.41B |
| Hemab Therapeutics Holdings | 1.41B |
| Tyra Biosciences | 1.41B |
| ArriVent BioPharma | 1.41B |
| Ascentage Pharma Group International | 1.37B |
| Kardigan | 1.36B |